NYSE:CAH - Cardinal Health Stock Price, Forecast & News

Cardinal Health's stock was trading at $48.65 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CAH shares have decreased by 4.0% and is now trading at $46.72. View which stocks have been mosted impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 1 sell rating, 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cardinal Health.

Cardinal Health is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Cardinal Health.

Cardinal Health Inc (NYSE:CAH) posted its earnings results on Thursday, February, 6th. The company reported $1.52 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.22 by $0.30. The company had revenue of $39.77 billion for the quarter, compared to analysts' expectations of $39.33 billion. Cardinal Health had a positive return on equity of 45.21% and a negative net margin of 2.81%. The firm's quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the prior year, the business posted $1.29 EPS. View Cardinal Health's earnings history.

Cardinal Health announced a quarterly dividend on Tuesday, February 11th. Stockholders of record on Wednesday, April 1st will be paid a dividend of $0.4811 per share on Wednesday, April 15th. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.12%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a positive change from Cardinal Health's previous quarterly dividend of $0.48. View Cardinal Health's dividend history.

Cardinal Health declared that its board has approved a stock repurchase program on Thursday, November 8th 2018, which permits the company to buyback $1,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase up to 6.4% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's board believes its shares are undervalued.

Cardinal Health issued an update on its FY20 earnings guidance on Thursday, February, 6th. The company provided earnings per share guidance of $5.20-5.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.00.

10 brokerages have issued 12 month target prices for Cardinal Health's shares. Their forecasts range from $50.00 to $68.00. On average, they anticipate Cardinal Health's share price to reach $56.88 in the next twelve months. This suggests a possible upside of 21.7% from the stock's current price. View analysts' price targets for Cardinal Health.

News coverage about CAH stock has trended very positive recently, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cardinal Health earned a coverage optimism score of 4.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the stock's share price in the near term. View the latest news aboutCardinal Health.

Cardinal Health saw a decline in short interest in the month of February. As of February 28th, there was short interest totaling 6,140,000 shares, a decline of 14.7% from the February 13th total of 7,200,000 shares. Based on an average trading volume of 2,770,000 shares, the days-to-cover ratio is presently 2.2 days. Approximately 2.1% of the company's stock are sold short. View Cardinal Health's Current Options Chain.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), Exxon Mobil (XOM), CVS Health (CVS), Becton Dickinson and (BDX), Chevron (CVX), Verizon Communications (VZ), Gilead Sciences (GILD) and PepsiCo (PEP).

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CAH stock can currently be purchased for approximately $46.72.

Cardinal Health has a market capitalization of $13.63 billion and generates $145.53 billion in revenue each year. The company earns $1.36 billion in net income (profit) each year or $5.28 on an earnings per share basis. Cardinal Health employs 31,000 workers across the globe. View additional information about Cardinal Health.

The official website for Cardinal Health is http://www.cardinalhealth.com/.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]